Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Other solid neoplasm 2Genitourinary 2Gastrointestinal 2CNS 2Gynecologic 1

Conditions

Multiple Myeloma 25Leukemia, Myeloid, Acute 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Lymphoma 21Burkitt Lymphoma 19Myelodysplastic Syndromes 18Leukemia 17Lymphoma, Non-Hodgkin 15Lymphoma, Follicular 15Lymphoma, Large B-Cell, Diffuse 14Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Mantle-Cell 12Lymphoma, B-Cell, Marginal Zone 12Neoplasms, Plasma Cell 11Lymphoma, Large-Cell, Immunoblastic 11Hodgkin Disease 11Breast Neoplasms 11Recurrence 10Congenital Abnormalities 9Sarcoma 8Myeloproliferative Disorders 8Dendritic Cell Sarcoma, Interdigitating 8Leukemia, Myelomonocytic, Juvenile 7Leukemia, Myeloid, Chronic-Phase 7Lymphoma, T-Cell, Cutaneous 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6Leukemia, Myeloid, Accelerated Phase 6Leukemia, Hairy Cell 6Central Nervous System Neoplasms 6Sezary Syndrome 5

Interventions

Thiotepa 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Busulfan 2sargramostim 1Stem Cell Transplantation 1Radiotherapy, Intensity-Modulated 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Ifosfamide 1Etoposide 1Cyproheptadine 1Bone Marrow Transplantation 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Hepatoblastoma × Filgrastim × Clear all
NCT00623077 2017-12-05

MT2004-30: Tomotherapy for Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
23 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor, Optic Nerve Glioma

NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡